Structural Heart Disease

Structural heart diseases include any issues preventing normal cardiovascular function due to damage or alteration to the anatomical components of the heart. This is caused by aging, advanced atherosclerosis, calcification, tissue degeneration, congenital heart defects and heart failure. The most commonly treated areas are the heart valves, in particular the mitral and aortic valves. These can be replaced through open heart surgery or using cath lab-based transcatheter valves or repairs to eliminate regurgitation due to faulty valve leaflets. This includes transcatheter aortic valve replacement (TAVR). Other common procedures include left atrial appendage (LAA) occlusion and closing congenital holes in the heart, such as PFO and ASD. A growing area includes transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

New cardiovascular intensive care unit offers specialized heart care for kids

Rady Children’s Hospital-San Diego today celebrated the grand opening of its new state-of-the-art Cardiovascular Intensive Care Unit (CVICU).

August 15, 2013

Henry Ford Hospital pioneers new cardiac approach

Doctors at Henry Ford Hospital have created a new route to the heart to implant an artificial heart valve by temporarily connecting major blood vessels that do not normally intersect.

August 14, 2013

Heart Healthy Lubbock: Program receives state award

The Texas Council on Cardiovascular Disease (CVD) and Stroke, in conjunction with the CVD & Stroke Program of the Texas Department of State Health Services, will present Healthy Lubbock with the Department of State Health Services 2013 Cardiovascular Health Promotions Award.

August 6, 2013

Cutting-edge pediatric heart treatments

The Wall Street Journal recently featured two pediatric approaches to treat children with congenital heart defects that cause them to be born with only one ventricle. The article and video are below.

August 6, 2013

JenaValve raises $62.5 million in venture funding

JenaValve Technology, Inc., a privately-held, venture-backed developer, manufacturer and marketer of transcatheter aortic valve implantation (TAVI) systems for the treatment of aortic valve disease, announced today that it has raised $62.5 million in a Series C venture round.

July 24, 2013

The Heart of Leonardo

A new book, The Heart of Leonardo, features all of Leonardo's drawings on the heart and its physiology, accompanied by translations of his accompanying notes.

July 18, 2013

Mutation as muse

Inspired by a genetic mutation that keeps low-density lipoprotein levels extremely low, three pharmaceutical companies are developing cholesterol drugs that mimic the trait. The New York Times described how drug makers are scurrying to get these potential blockbusters to market.

July 10, 2013

Saint Luke's expands cardio wellness center services with opening of new Charles & Barbara Duboc Cardio Health & Wellness Center at Saint Luke's Hospital

The Charles & Barbara Duboc Cardio Health & Wellness Center is ushering in a new era for preventive cardiac care at Saint Luke's Hospital..

July 8, 2013

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup